abiraterone,olaparib
astrazeneca,merck
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'propel']
interesting os curve from propel with a separation after 22 months, coincident with the rpfs. is the post-progression therapy influencing this data? #gu23 
Scientific Committee Member LACOG - GU. Medical Oncologist at Hospital Albert Einstein and CPO. Owner and founder BIO. Following or RT does not mean endorsement